Cas 625117-31-9,N-(2,6-dimethylphenyl)-N-(1,1-dioxohexahydropyran-4-formyl)glycine ethyl ester

625117-31-9

Post Buying Request

Basic information

Product Name: N-(2,6-dimethylphenyl)-N-(1,1-dioxohexahydropyran-4-formyl)glycine ethyl ester
Synonyms: N-(2,6-dimethylphenyl)-N-(1,1-dioxohexahydropyran-4-formyl)glycine ethyl ester
CAS NO:625117-31-9
Molecular Formula:
Molecular Weight: 367.466
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(2,6-dimethylphenyl)-N-(1,1-dioxohexahydropyran-4-formyl)glycine ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: N-(2,6-dimethylphenyl)-N-(1,1-dioxohexahydropyran-4-formyl)glycine ethyl ester(625117-31-9)
EPA Substance Registry System: N-(2,6-dimethylphenyl)-N-(1,1-dioxohexahydropyran-4-formyl)glycine ethyl ester(625117-31-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 625117-31-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

625117-31-9 Suppliers

Recommended suppliers

625117-31-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 625117-31-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,5,1,1 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 625117-31:
(8*6)+(7*2)+(6*5)+(5*1)+(4*1)+(3*7)+(2*3)+(1*1)=129
129 % 10 = 9
So 625117-31-9 is a valid CAS Registry Number.

625117-31-9Upstream product

625117-31-9Downstream Products

625117-31-9Relevant academic research and scientific papers

Preparation method of amenamevir and intermediate thereof

-

, (2018/11/22)

The invention discloses a preparation method of amenamevir and an intermediate thereof. The invention provides a preparation method of a compound as shown in a formula (V). The preparation method comprises the following steps: adding a compound as shown i

THERAPEUTIC AGENT FOR HERPES PROGENITALIS

-

Page/Page column 8-9, (2008/06/13)

[PROBLEMS] To provide a medicament useful for the treatment of genital herpes after the development of lesions. [MEANS FOR SOLVING PROBLEMS] An N-[2-[(4-substituted phenyl)amino]-2-oxoethyl]tetrahydro-2H-thiopyran-4-carboxamide derivative in which the phe

AGENT FOR PREVENTION/TREATMENT OF DISEASE CAUSED BY ACYCLOVIR-RESISTANT HERPESVIRUS

-

Page/Page column 8-9, (2008/06/13)

[PROBLEMS] To provide an agent useful for the prevention or treatment of various diseases associated with the infection with acyclovir-resistant viruses of the family Herpesviridae, specifically various infectious caused by herpesviruses, such as varicell

PREVENTIVE OR THERAPEUTIC AGENT FOR HERPESVIRUS-RELATED DISEASE

-

Page/Page column 12, (2008/06/13)

[PROBLEMS] To provide a medicament, particularly a pharmaceutical composition useful for preventing or treating a variety of diseases caused by infection of a virus of the Herpesviridae family. [MEANS FOR SOLVING PROBLEMS] The present invention relates to

Tetrahydro-2H-thiopyran-4-carboxamide derivative

-

Page 7; 8, (2008/06/13)

A pharmaceutical drug, particularly a novel compound useful for the prophylaxis or therapeutic treatment of various diseases involving infections with viruses of the Herpesviridae family, specifically various herpesvirus infections such as varicella (chic

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 625117-31-9